Search Result
        
        
            
                Results for "
PBP
" in MedChemExpress (MCE) Product Catalog:
            
         
        
        
            
                
            
            
            
            
            
                
            
            
            
                
            
            
                
            
            
                
            
            
                
                    7
Isotope-Labeled Compounds
 
            
            
                
            
            
            
                
            
         
        
            
            
                
                    
                    
                        
                            | Cat. No. | Product Name | Target | Research Areas | Chemical Structure | 
                    
                    
                        
                            
                            - 
                                
                                    - HY-W105318
- 
                                        
                                            
                                                | PBP | TGF-beta/Smad
                                                    
                                                        Apoptosis | Cancer |  
                                                | Pentabromophenol (PBP) is a brominated flame retardant (BFR) widely used in various consumer products to reduce the flammability of materials used in different utility items. Pentabromophenol can accelerate the degradation of transforming growth factor-β (TGF-β) receptors by promoting clathrin-mediated endocytosis, thereby inhibiting the TGF-β signaling pathway. Additionally, Pentabromophenol can also induce apoptosis in peripheral blood mononuclear cells (PBMCs)  . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-P1116
- 
                                        
                                            
                                                | 
                                                        
                                                            PBP10
                                                            
                                                        
                                                        
                                                            
                                                                
                                                                
                                                                
                                                                    1 Publications Verification | Bacterial | Infection
                                                    
                                                        Inflammation/Immunology |  
                                                | PBP10 is a cell permeable and selective gelsolin-derived peptide inhibitor of formyl peptide receptor 2 (FPR2) over FPR1 . PBP10 is a 10-AA peptide with rhodamine conjugated at its N terminus, exerts bactericidal activity against gram-positive and gram-negative bacteria and limits microbial-induced inflammatory effects . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-P1116A
- 
                                        
                                            
                                                |  | Bacterial | Infection
                                                    
                                                        Inflammation/Immunology |  
                                                | PBP10 is a cell permeable and selective gelsolin-derived peptide inhibitor of formyl peptide receptor 2 (FPR2) over FPR1 . PBP10 is a 10-AA peptide with rhodamine conjugated at its N terminus, exerts bactericidal activity against gram-positive and gram-negative bacteria and limits microbial-induced inflammatory effects . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B1257
- 
                                        
                                            
                                                | Sodium cefmetazole | Bacterial
                                                    
                                                        Antibiotic | Infection
                                                    
                                                        Cancer |  
                                                | Cefmetazole sodium (Sodium cefmetazole) is a semisynthetic cephamycin antibiotic with broad-spectrum antibacterial activity, covering gram-positive, gram-negative, and anaerobic bacteria. Cefmetazole sodium binds to penicillin binding proteins (PBPs), resulting in interfering bacterial cell wall biosynthesis. Cefmetazole sodium is used for the research of gynecologic, intraabdominal, urinary tract, respiratory tract and skin and soft tissue infections   . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B1595
- 
                                        
                                            
                                                | CS 1170 | Antibiotic
                                                    
                                                        Bacterial | Infection
                                                    
                                                        Cancer |  
                                                | Cefmetazole (CS 1170) is a semisynthetic cephamycin antibiotic with broad-spectrum antibacterial activity, covering gram-positive, gram-negative and anaerobic bacteria. Cefmetazole binds to penicillin binding proteins (PBPs), resulting in interfering bacterial cell wall biosynthesis. Cefmetazole is used for the research of gynecologic, intraabdominal, urinary tract, respiratory tract and skin and soft tissue infections   . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-173197
- 
                                        
                                            
                                                |  | Bacterial | Infection |  
                                                | PBP4-IN-1 (Compound 1) is an inhibitor of penicillin-binding protein 4 (PBP4) of Staphylococcus aureus. PBP4-IN-1 enhances the inhibitory activity of antibiotics against PBP2a-mediated methicillin-resistant Staphylococcus aureus (MRSA) by inhibiting the function of PBP4. PBP4-IN-1 can be used for the study of osteomyelitis caused by Staphylococcus aureus and for the study of reversing PBP4-mediated resistance to β-lactam antibiotics. |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-P10825
- 
                                        
                                            
                                                |  | DNA/RNA Synthesis | Cancer |  
                                                | p21PBP, a 20 amino-acid peptide, is an inhibitor of DNA replication. p21PBP specifically binds to purified proliferating cell nuclear antigen (PCNA) in tumour cell extracts. p21PBP is promising for research of cancers . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-116519
- 
                                        
                                            
                                                |  | Bacterial | Infection |  
                                                | LY173013 is an antibacterial agent with a broad spectrum antibacterial activity. LY173013 binds to PBP 3 of E.coli and can be utilized in antibacterial research . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-Z7592
- 
                                        
                                            
                                                | (E)-THR-221 | Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Penicillin-binding protein (PBP) | Infection |  
                                                | (E)-Cefodizime ((E)-THR-221) is an antibiotic. (E)-Cefodizime can selectively bind to penicillin-binding proteins (PBPs) and inhibit the synthesis of the bacterial cell wall, thereby exerting antibacterial activity. (E)-Cefodizime is promising for research of various bacterial infectious diseases, such as for preoperative infection prophylaxis . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-114913
- 
                                        
                                            
                                                | EL 222 | Androgen Receptor
                                                    
                                                        Bacterial | Infection
                                                    
                                                        Endocrinology |  
                                                | Fenarimol (EL 222) is a potent and orally active fungicide. Fenarimol also is a androgen receptor inhibitor with an IC50 value of 19 µM. Fenarimol decreases the mRNA expression of PBP C3, ODC, IGF-1 . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B1257R
- 
                                        
                                            
                                                | Sodium cefmetazole (Standard) | Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic | Infection
                                                    
                                                        Cancer |  
                                                | Cefmetazole (sodium) (Standard) is the analytical standard of Cefmetazole (sodium). This product is intended for research and analytical applications. Cefmetazole sodium (Sodium cefmetazole) is a semisynthetic cephamycin antibiotic with broad-spectrum antibacterial activity, covering gram-positive, gram-negative, and anaerobic bacteria. Cefmetazole sodium binds to penicillin binding proteins (PBPs), resulting in interfering bacterial cell wall biosynthesis. Cefmetazole sodium is used for the research of gynecologic, intraabdominal, urinary tract, respiratory tract and skin and soft tissue infections   . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-117736
- 
                                        
                                            
                                                |  | Penicillin-binding protein (PBP)
                                                    
                                                        Bacterial | Infection
                                                    
                                                        Inflammation/Immunology |  
                                                | Ro 09-1428 is a broad-spectrum parenteral cephalosporin. Ro 09-1428 has potent antibacterial activities against Pseudomonas aeruginosa and Acinetobacter caloaceticus, with MIC90s of 0.39 and 6.25 μg/mL, respectively, better than Ceftazidime (HY-B0593). Additionally, Ro 09-1428 shows high activity against Escherichia coli, Kkbsielia pneumoniae, Proteus mirabilis, P. aeruginosa, staphylococci, and more. Ro 09-1428 preferentially attacks PBP 3 for target in E. coli and P. aeruginosa, which is promising for research of septicemias and serious P. aeruginosa infections  . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0129
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-129949
- 
                                        
                                            
                                                |  | Antibiotic
                                                    
                                                        Bacterial | Infection
                                                    
                                                        Cancer |  
                                                | Aztreonam (lysine) is a monocyclic beta-lactam antibiotic, and has a very high affinity for penicillin-binding protein 3 (PBP-3). Aztreonam (lysine) is active against Gram-negative aerobic bacteria  . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0129S
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0129R
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-120366
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-19806A
- 
                                        
                                            
                                                | CXA-101;  FR264205 | Bacterial | Infection |  
                                                | Ceftolozane (CXA-101) sulfate is an antipseudomonal cephalosporin. Ceftolozane binds to P. aeruginosa essential PBPs (1b, 1c, 2 and 3) with high affinity. Ceftolozane inhibits cell wall synthesis by binding the PBPs. Ceftolozane sulfate inhibits P. aeruginosa and Enterobacteriaceae       . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-139744
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-126387
- 
                                        
                                            
                                                |  | Antibiotic
                                                    
                                                        Bacterial | Infection |  
                                                | Moenomycin complex is a potent transglycosylase inhibitor. Moenomycin complex inhibits bacterial growth by blocking the transglycosylase activity of class A penicillin-binding proteins (PBPs) . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0198S
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0396
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-120859A
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-120859
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0396A
- 
                                        
                                            
                                                | L084 hydrochloride | Penicillin-binding protein (PBP)
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic | Infection |  
                                                | Tebipenem pivoxil (L084) hydrochloride is an orally active antibiotic against a variety of pathogenic bacteria. Tebipenem pivoxil hydrochloride binds penicillin-binding protein (PBP), thereby inhibiting cell wall synthesis . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B1596A
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B1325
- 
                                        
                                            
                                                |  | Bacterial
                                                    
                                                        Antibiotic | Infection
                                                    
                                                        Inflammation/Immunology |  
                                                | Cefuroxime axetil is an orally effective broad-spectrum β-lactam antibiotic that targets bacterial penicillin-binding proteins (PBPs, such as PBP3 and PBP1). Cefuroxime axetil inhibits cell wall synthesis, leading to bacterial lysis and death, with a minimum inhibitory concentration (MIC) of 0.12-4 mg/L for non-typeable Haemophilus influenzae (NTHi). Cefuroxime axetil is hydrolyzed by esterase to the active ingredient Cefuroxime (HY-B1256A) after oral absorption. Topical administration of Cefuroxime via bioadhesive nanoparticles (BNPs) can prolong the drug's retention time in the middle ear (≥7 days). Cefuroxime axetil can be used in the study of otitis media (especially NTHi infection). Cefuroxime axetil can achieve precise antibacterial effects through oral or topical nano-delivery systems, reducing systemic exposure and the risk of antibiotic resistance   . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-RS03925
- 
                                        
                                            
                                                |  | Small Interfering RNA (siRNA) | Others |  
                                                | DOCK3 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                 |  
 
- 
                                        
                                            DOCK3 Human Pre-designed siRNA Set A
                                            
                                                DOCK3 Human Pre-designed siRNA Set A
                                             
 
- 
                                
                                    - HY-RS24550
- 
                                        
                                            
                                                |  | Small Interfering RNA (siRNA) | Others |  
                                                | Pebp1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Pebp1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                 |  
 
- 
                                        
                                            Pebp1 Rat Pre-designed siRNA Set A
                                            
                                                Pebp1 Rat Pre-designed siRNA Set A
                                             
 
- 
                                
                                    - HY-A0111B
- 
                                        
                                            
                                                | Ro 15-8074 hydrochloride; Deacetoxycefotaxime hydrochloride | Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Penicillin-binding protein (PBP)
                                                    
                                                        Drug Metabolite | Infection |  
                                                | Cefetamet (Ro 15-8074) hydrochloride is a cephalosporin antibiotic and the active metabolite of Cefetamet pivoxil (HY-B1894A). Cefetamet hydrochloride binds to bacterial penicillin-binding protein (PBP) (IC50 for PBP3 in Escherichia coli W3110 is 2.5 μg/mL). Cefetamet hydrochloride has significant activity against Gram-negative bacteria such as Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria such as Streptococcus. Cefetamet hydrochloride kills and lyses Treponema pallidum. Cefetamet hydrochloride can be used in the research of respiratory tract, urinary tract, ear, nose and throat infections, and syphilis     . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-A0111A
- 
                                        
                                            
                                                | Ro15-8074/001; Deacetoxycefotaxime sodium | Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Penicillin-binding protein (PBP)
                                                    
                                                        Drug Metabolite | Infection |  
                                                | Cefetamet (Ro 15-8074) sodium is a cephalosporin antibiotic and the active metabolite of Cefetamet pivoxil (HY-B1894A). Cefetamet sodium binds to bacterial penicillin-binding protein (PBP) (IC50 for PBP3 in Escherichia coli W3110 is 2.5 μg/mL). Cefetamet sodium has significant activity against Gram-negative bacteria such as Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria such as Streptococcus. Cefetamet sodium kills and lyses Treponema pallidum. Cefetamet sodium can be used in the research of respiratory tract, urinary tract, ear, nose and throat infections, and syphilis     . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-A0111
- 
                                        
                                            
                                                | Ro 15-8074;  Deacetoxycefotaxime | Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Penicillin-binding protein (PBP)
                                                    
                                                        Drug Metabolite | Infection |  
                                                | Cefetamet (Ro 15-8074) is a cephalosporin antibiotic and the active metabolite of Cefetamet pivoxil (HY-B1894A). Cefetamet binds to bacterial penicillin-binding protein (PBP) (IC50 for PBP3 in Escherichia coli W3110 is 2.5 μg/mL). Cefetamet has significant activity against Gram-negative bacteria such as Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria such as Streptococcus. Cefetamet kills and lyses Treponema pallidum. Cefetamet can be used in the research of respiratory tract, urinary tract, ear, nose and throat infections, and syphilis     . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-109008
- 
                                        
                                            
                                                | OP0595 free acid | Beta-lactamase
                                                    
                                                        Bacterial | Infection |  
                                                | Nacubactam (OP0595 free acid) is a potent non-β-lactam-β-lactamase inhibitor with activity against class A and C β-lactamases. Nacubactam acts as a penicillin binding protein (PBP) 2-active antibacterial, and gives β-lactamase-independent potentiation of β-lactams targeting other PBPs. Nacubactam potentiates the antimicrobial activities of Piperacillin (HY-B1923), Cefepime (HY-B0692), and Meropenem (HY-13678) against CTX-M-15-positive Escherichia coli and KPC-positive Klebsiella pneumoniae      . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-121544A
- 
                                        
                                            
                                                |  | Penicillin-binding protein (PBP)
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Histamine Receptor | Infection |  
                                                | Methicillin sodium hydrate is a narrow-spectrum β-lactam antibiotic, acts by inhibiting penicillin-binding proteins (PBPs). Methicillin sodium hydrate is active against Staphylococcus aureus and Staphylococcus epidermidis that are resistant to other penicillins. Methicillin sodium hydrate can be used for the research of skin infections, osteomyelitis, and endocarditis . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-121544
- 
                                        
                                            
                                                |  | Penicillin-binding protein (PBP)
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Histamine Receptor | Infection |  
                                                | Methicillin is a narrow-spectrum β-lactam antibiotic, acts by inhibiting penicillin-binding proteins (PBPs). Methicillin is active against Staphylococcus aureus and Staphylococcus epidermidis that are resistant to other penicillins.Methicillin can be used for the research of skin infections, osteomyelitis, and endocarditis . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-114780
- 
                                        
                                            
                                                |  | Penicillin-binding protein (PBP)
                                                    
                                                        Bacterial | Infection |  
                                                | Lactivicin is a non-beta-lactam antibiotic showing beta-lactam action through binding to penicillin-binding protein (PBP). Lactivicin is moderately active against a wide range of Gram-negative bacteria and highly active against Gram-positive bacteria . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-120859R
- 
                                        
                                            
                                                |  | Beta-lactamase
                                                    
                                                        Penicillin-binding protein (PBP)
                                                    
                                                        Bacterial | Infection |  
                                                | Zidebactam (Standard) is the analytical standard of Zidebactam. This product is intended for research and analytical applications. Zidebactam (WCK-5107) is a potent β-lactamase inhibitor . Zidebactam also is a penicillin-binding protein2 (PBP2) inhibitor with an IC50 of 0.26 μg/mL . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-A0111R
- 
                                        
                                            
                                                | Ro 15-8074 (Standard); Deacetoxycefotaxime (Standard) | Reference Standards
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Penicillin-binding protein (PBP)
                                                    
                                                        Drug Metabolite | Infection |  
                                                | Cefetamet (Standard) is the analytical standard of Cefetamet (HY-A0111). This product is intended for research and analytical applications. Cefetamet (Ro 15-8074) is a cephalosporin antibiotic and the active metabolite of Cefetamet pivoxil (HY-B1894A). Cefetamet binds to bacterial penicillin-binding protein (PBP) (IC50 for PBP3 in Escherichia coli W3110 is 2.5 μg/mL). Cefetamet has significant activity against Gram-negative bacteria such as Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria such as Streptococcus. Cefetamet kills and lyses Treponema pallidum. Cefetamet can be used in the research of respiratory tract, urinary tract, ear, nose and throat infections, and syphilis     . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-174459
- 
                                        
                                            
                                                |  | Bacterial
                                                    
                                                        Penicillin-binding protein (PBP) | Infection |  
                                                | Anti-MRSA agent 31 (Compound 6) is an anti-methicillin-resistant Staphylococcus aureus (MRSA)  agent with a MIC of 97 μg/mL and a MBC of 781.25 μg/mL. Anti-MRSA agent 31 has a potent antibacterial activity and a strong Binding Protein 2a (PBP2a) inhibitory activity . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0396R
- 
                                        
                                            
                                                | L084 (Standard) | Penicillin-binding protein (PBP)
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic | Infection |  
                                                | Tebipenem pivoxil (Standard) is the analytical standard of Tebipenem pivoxil. This product is intended for research and analytical applications. Tebipenem pivoxil (L084) is an orally active antibiotic against a variety of pathogenic bacteria. Tebipenem pivoxil binds penicillin-binding protein (PBP), thereby inhibiting cell wall synthesis[1]. |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-W743473
- 
                                        
                                            
                                                | Ro 15-8074-d3;  Deacetoxycefotaxime-d3 | Isotope-Labeled Compounds
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Penicillin-binding protein (PBP)
                                                    
                                                        Drug Metabolite | Infection |  
                                                | Cefetamet-d3 (Ro 15-8074-d3; Deacetoxycefotaxime-d3) is the deuterium labeled Cefetamet (HY-A0111). Cefetamet (Ro 15-8074) is a cephalosporin antibiotic and the active metabolite of Cefetamet pivoxil (HY-B1894A). Cefetamet binds to bacterial penicillin-binding protein (PBP) (IC50 for PBP3 in Escherichia coli W3110 is 2.5 μg/mL). Cefetamet has significant activity against Gram-negative bacteria such as Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria such as Streptococcus. Cefetamet kills and lyses Treponema pallidum. Cefetamet can be used in the research of respiratory tract, urinary tract, ear, nose and throat infections, and syphilis     . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0198A
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0198
- 
                                        
                                    
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-139745A
- 
                                        
                                            
                                                |  | Beta-lactamase
                                                    
                                                        Bacterial | Infection |  
                                                | FPI-1523, a derivative of Avibactam, is a potent β-lactamase inhibitor, with Kds of 4 nM and 34 nM for CTX-M-15 and OXA-48, respectively. FPI-1523 also inhibits PBP2, with an IC50 of 3.2 μM. FPI-1523 exhibits considerable antimicrobial activity . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-150063
- 
                                        
                                            
                                                |  | Penicillin-binding protein (PBP)
                                                    
                                                        Bacterial | Infection |  
                                                | Antibacterial agent 116 is a benzophenone-containing salicylanilide compound. Antibacterial agent 116 has potent antibacterial activity by inhibiting the peptidoglycan formation. Antibacterial agent 116 is used as a photoaffinity probe to label Acinetobacter baumannii penicillin-binding protein (PBP1b), block the propagation pathway to disrupt the growth of peptidoglycan chain . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-139745
- 
                                        
                                            
                                                |  | Beta-lactamase
                                                    
                                                        Bacterial | Infection |  
                                                | FPI-1523 sodium, a derivative of Avibactam, is a potent β-lactamase inhibitor, with Kds of 4 nM and 34 nM for CTX-M-15 and OXA-48, respectively. FPI-1523 sodium also inhibits PBP2, with an IC50 of 3.2 μM. FPI-1523 sodium exhibits considerable antimicrobial activity . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-121544AR
- 
                                        
                                            
                                                |  | Penicillin-binding protein (PBP)
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Histamine Receptor | Infection |  
                                                | Methicillin (sodium hydrate) (Standard) is the analytical standard of Methicillin (sodium hydrate). This product is intended for research and analytical applications. Methicillin sodium hydrate is a narrow-spectrum β-lactam antibiotic, acts by inhibiting penicillin-binding proteins (PBPs). Methicillin sodium hydrate is active against Staphylococcus aureus and Staphylococcus epidermidis that are resistant to other penicillins. Methicillin sodium hydrate can be used for the research of skin infections, osteomyelitis, and endocarditis . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-18719ER
- 
                                        
                                            
                                                |  | Cytochrome P450
                                                    
                                                        Reference Standards
                                                    
                                                        Estrogen Receptor/ERR
                                                    
                                                        Drug Metabolite
                                                    
                                                        Parasite | Cancer |  
                                                | Methicillin (sodium hydrate) (Standard) is the analytical standard of Methicillin (sodium hydrate). This product is intended for research and analytical applications. Methicillin sodium hydrate is a narrow-spectrum β-lactam antibiotic, acts by inhibiting penicillin-binding proteins (PBPs). Methicillin sodium hydrate is active against Staphylococcus aureus and Staphylococcus epidermidis that are resistant to other penicillins. Methicillin sodium hydrate can be used for the research of skin infections, osteomyelitis, and endocarditis . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-106922
- 
                                        
                                            
                                                | GV104326 | Antibiotic
                                                    
                                                        Bacterial | Infection |  
                                                | Sanfetrinem (GV104326) is a β-lactamase-stable antibiotic. Sanfetrinem has broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-121329
- 
                                        
                                            
                                                | AMA-1080;  Ro 17-2301 | Penicillin-binding protein (PBP)
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial | Infection |  
                                                | Carumonam (AMA-1080; Ro 17-2301) is a sulfonated monocyclic β-Lactam Antibiotic, targeting to penicillin-binding protein (PBP). Carumonam exerts highly activity against Enterobacteriaceae, Pseudomonas aeruginosa, and Haemophilus influenzae, while it weakly and even inactively inhibits Streptococcus pneumoniae and Staphylococcus aureus. Carumonam is resistant to beta-lactamase-mediated hydrolysis . |  
 
- 
                                        
                                        
                                              
 
                                    - HY-19071
- 
                                        
                                            
                                                |  | Antibiotic
                                                    
                                                        Bacterial | Infection |  
                                                | BK-218 is an orally active cephalosporin antibiotic that binds to penicillin-binding proteins (PBPs) and has a greater inhibitory effect than Cephalexin (HY-B0200) and Cefoxitin (HY-B1825). BK-218 has similar antibacterial activity to Cefamandole (HY-B1128) and can be used in the development of antibacterial drugs . |  
 
- 
                                        
                                        
                                              
                                    - HY-RS00003
- 
                                        
                                            
                                                |  | Small Interfering RNA (siRNA)
                                                    
                                                        PKD | Others |  
                                                | PKD1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                 |  
 
- 
                                        
                                            PKD1 Human Pre-designed siRNA Set A
                                            
                                                PKD1 Human Pre-designed siRNA Set A
                                             
                                    - HY-RS18075
- 
                                        
                                            
                                                |  | Small Interfering RNA (siRNA) | Others |  
                                                | Pebp1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pebp1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                 |  
 
- 
                                        
                                            Pebp1 Mouse Pre-designed siRNA Set A
                                            
                                                Pebp1 Mouse Pre-designed siRNA Set A
                                             
                                    - HY-B0198R
- 
                                        
                                    
- 
                                        
                                        
                                              
                                    - HY-B0200
- 
                                        
                                            
                                                | Cefalexin;  Cephacillin | Penicillin-binding protein (PBP)
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial | Infection
                                                    
                                                        Cancer |  
                                                | Cephalexin (Cefalexin) is a potent, orally active semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al  . |  
 
- 
                                        
                                        
                                              
                                    - HY-D0184R
- 
                                        
                                            
                                                | Deoxycytidine (Standard); Cytosine deoxyriboside (Standard); Deoxyribose cytidine (Standard) | Reference Standards
                                                    
                                                        Endogenous Metabolite | Cancer |  
                                                | Cefaclor (monohydrate) (Standard) is the analytical standard of Cefaclor (monohydrate). This product is intended for research and analytical applications. Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections    . |  
 
- 
                                        
                                        
                                              
                                    - HY-13588
- 
                                        
                                            
                                                | SCE-129 sodium | Bacterial
                                                    
                                                        Antibiotic | Infection |  
                                                | Cefsulodin (SCE-129) sodium is a third generation β lactam antibiotic and member of the cephems subgroup of antibiotics. Cefsulodin sodium inhibits cell wall synthesis by competitively inhibiting penicillin binding protein (PBP) cross-linking and transpeptidation of peptidogly. Cefsulodin sodium is a potent tyrosine phosphatase inhibitor against mPTPB, a virulent phosphatase from Mycobacterium tuberculosis, with an IC50 value of 16 μM    . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0198AR
- 
                                        
                                    
- 
                                        
                                        
                                              
                                    - HY-13588B
- 
                                        
                                            
                                                | SCE-129 sodium hydrate | Antibiotic
                                                    
                                                        Bacterial | Infection |  
                                                | Cefsulodin (SCE-129) sodium is a third generation β lactam antibiotic and member of the cephems subgroup of antibiotics. Cefsulodin sodium inhibits cell wall synthesis by competitively inhibiting penicillin binding protein (PBP) cross-linking and transpeptidation of peptidogly. Cefsulodin sodium is a potent tyrosine phosphatase inhibitor against mPTPB, a virulent phosphatase from Mycobacterium tuberculosis, with an IC50 value of 16 μM    . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0200A
- 
                                        
                                            
                                                | Cefalexin hydrochloride;  Cephacillin hydrochloride | Penicillin-binding protein (PBP)
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic | Infection
                                                    
                                                        Cancer |  
                                                | Cephalexin (Cefalexin) hydrochloride is a potent, orally active new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin (Cefalexin) hydrochloride has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin (Cefalexin) hydrochloride targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin (Cefalexin) hydrochloride is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al  . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0200C
- 
                                        
                                            
                                                | Cefalexin hydrochloride monohydrate; Cephacillin hydrochloride monohydrate | Penicillin-binding protein (PBP)
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial | Infection
                                                    
                                                        Cancer |  
                                                | Cephalexin (Cefalexin) hydrochloride monohydrate is a potent, orally active new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin (Cefalexin) hydrochloride monohydrate has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin (Cefalexin) hydrochloride monohydrate targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin (Cefalexin) hydrochloride monohydrate is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al  . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0200D
- 
                                        
                                            
                                                | Cefalexin (lysine);  Cephacillin (lysine) | Penicillin-binding protein (PBP)
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic | Infection
                                                    
                                                        Cancer |  
                                                | Cephalexin (Cefalexin) lysine is a potent, orally active new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin lysine has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin lysine targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin lysine is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al  . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0200B
- 
                                        
                                            
                                                | Cefalexin hydrate;  Cephacillin hydrate | Penicillin-binding protein (PBP)
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial | Infection
                                                    
                                                        Cancer |  
                                                | Cephalexin (Cefalexin) monohydrate is a potent, orally active new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin (Cefalexin) monohydrate has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin (Cefalexin) monohydrate targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin (Cefalexin) monohydrate is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al  . |  
 
- 
                                        
                                        
                                              
                                    - HY-N7101S1
- 
                                        
                                            
                                                | U-76,252-d6;  CS-807-d6 | Isotope-Labeled Compounds
                                                    
                                                        Penicillin-binding protein (PBP)
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic | Infection |  
                                                | Cefpodoxime Proxetil-d6 (U-76,252-d6) is deuterium labeled Cefpodoxime Proxetil. Cefpodoxime proxetil is an orally administered broad spectrum third-generation cephalosporin. Cefpodoxime proxetil has anti-bacterial activity. Cefpodoxime proxetil binds to penicillin binding proteins (PBPs) which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis  . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0026
- 
                                        
                                            
                                                |  | Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        NF-κB
                                                    
                                                        p38 MAPK
                                                    
                                                        TNF Receptor
                                                    
                                                        Interleukin Related | Infection |  
                                                | Ceftiofur hydrochloride is a cell wall synthesis inhibitor that targets bacterial penicillin-binding proteins (PBPs) and has anti-inflammatory effects in endotoxemia. Ceftiofur hydrochloride exerts bactericidal effects by inhibiting the synthesis of bacterial cell wall peptidoglycan, leading to bacterial cell lysis. Ceftiofur hydrochloride also inhibits the activation of NF-κB and MAPKs, thereby reducing the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6   . |  
 
- 
                                        
                                        
                                              
                                    - HY-W013376
- 
                                        
                                            
                                                | 1-(Diphenylmethyl)piperazine;  1-Benzhydrylpiperazine | Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Penicillin-binding protein (PBP) | Infection
                                                    
                                                        Cancer |  
                                                | Norcyclizine is a piperazine compound that can be used for the synthesis of antimicrobial agents. 1-Benzhydrylpiperazine derivatives have been found to enhance the antibacterial activity of β-lactam antibiotics (Oxacillin, HY-B0925A) against Methicillin (HY-121544)-resistant Staphylococcus aureus (MRSA). This enhancement is likely achieved by inhibiting the allosteric site of PBP2a. Additionally, 1-Benzhydrylpiperazine can also serve as a pharmacological scaffold for the synthesis of anticancer agents  . |  
 
- 
                                        
                                        
                                              
                                    - HY-178108
- 
                                        
                                            
                                                |  | Bacterial
                                                    
                                                        Penicillin-binding protein (PBP)
                                                    
                                                        Fungal | Infection |  
                                                | Anti-MRSA agent 35 (Compound 6b) is an anti-MRSA agent. Anti-MRSA agent 35 significantly inhibits MRSA biofilm formation, suppresses penicillin-binding protein (PBP2a) expression and induces mecA virulence gene mutation. Anti-MRSA agent 35 has potent bactericidal and fungicidal activities with MIC50s of 7.8-31.25 μg/mL for gram positive bacteria, gram-negative bacteria and Fungi.  . |  
 
- 
                                        
                                        
                                              
                                    - HY-N7102
- 
                                        
                                            
                                                |  | Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        NF-κB
                                                    
                                                        p38 MAPK
                                                    
                                                        TNF Receptor
                                                    
                                                        Interleukin Related | Infection |  
                                                | Ceftiofur is a cell wall synthesis inhibitor that targets bacterial penicillin-binding proteins (PBPs) and has anti-inflammatory effects in endotoxemia. Ceftiofur exerts bactericidal effects by inhibiting the synthesis of bacterial cell wall peptidoglycan, leading to bacterial cell lysis. Ceftiofur also inhibits the activation of NF-κB and MAPKs, thereby reducing the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6   . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0898
- 
                                        
                                            
                                                | sodium ceftiofur | Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        NF-κB
                                                    
                                                        p38 MAPK
                                                    
                                                        TNF Receptor
                                                    
                                                        Interleukin Related | Infection |  
                                                | Ceftiofur sodium is a cell wall synthesis inhibitor that targets bacterial penicillin-binding proteins (PBPs) and has anti-inflammatory effects in endotoxemia. Ceftiofur sodium exerts bactericidal effects by inhibiting the synthesis of bacterial cell wall peptidoglycan, leading to bacterial cell lysis. Ceftiofur sodium also inhibits the activation of NF-κB and MAPKs, thereby reducing the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6   . |  
 
- 
                                        
                                        
                                              
                                    - HY-W653936
- 
                                        
                                            
                                                |  | Isotope-Labeled Compounds
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Penicillin-binding protein (PBP) | Cancer |  
                                                | Cephalexin-d5 (hydrate) is deuterium labeled Cephalexin (monohydrate). Cephalexin (Cefalexin) monohydrate is a potent, orally active new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin (Cefalexin) monohydrate has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin (Cefalexin) monohydrate targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin (Cefalexin) monohydrate is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al   . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0200R
- 
                                        
                                            
                                                | Cefalexin (Standard); Cephacillin (Standard) | Penicillin-binding protein (PBP)
                                                    
                                                        Reference Standards
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial | Infection
                                                    
                                                        Cancer |  
                                                | Cephalexin (Standard) is the analytical standard of Cephalexin. This product is intended for research and analytical applications. Cephalexin (Cefalexin) is a potent, orally active semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al  . |  
 
- 
                                        
                                        
                                              
                                    - HY-13588R
- 
                                        
                                            
                                                | SCE-129 sodium (Standard) | Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic | Infection |  
                                                | Cefsulodin (sodium) (Standard) is the analytical standard of Cefsulodin (sodium). This product is intended for research and analytical applications. Cefsulodin (SCE-129) sodium is a third generation β lactam antibiotic and member of the cephems subgroup of antibiotics. Cefsulodin sodium inhibits cell wall synthesis by competitively inhibiting penicillin binding protein (PBP) cross-linking and transpeptidation of peptidogly. Cefsulodin sodium is a potent tyrosine phosphatase inhibitor against mPTPB, a virulent phosphatase from Mycobacterium tuberculosis, with an IC50 value of 16 μM    . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0200BR
- 
                                        
                                            
                                                | Cefalexin hydrate (Standard); Cephacillin hydrate (Standard) | Penicillin-binding protein (PBP)
                                                    
                                                        Reference Standards
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial | Infection
                                                    
                                                        Cancer |  
                                                | Cephalexin (monohydrate) (Standard) is the analytical standard of Cephalexin (monohydrate). This product is intended for research and analytical applications. Cephalexin (Cefalexin) monohydrate is a potent, orally active new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin (Cefalexin) monohydrate has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin (Cefalexin) monohydrate targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin (Cefalexin) monohydrate is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al  . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0200AR
- 
                                        
                                            
                                                | Cefalexin hydrochloride (Standard); Cephacillin hydrochloride (Standard) | Penicillin-binding protein (PBP)
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic | Infection
                                                    
                                                        Cancer |  
                                                | Cephalexin (hydrochloride) (Standard) is the analytical standard of Cephalexin (hydrochloride). This product is intended for research and analytical applications. Cephalexin (Cefalexin) hydrochloride is a potent, orally active new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin (Cefalexin) hydrochloride has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin (Cefalexin) hydrochloride targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin (Cefalexin) hydrochloride is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al[1][2]. |  
 
- 
                                        
                                        
                                              
                                    - HY-RS18247
- 
                                        
                                            
                                                |  | Small Interfering RNA (siRNA) | Others |  
                                                | Med1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Med1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                 |  
 
- 
                                        
                                            Med1 Mouse Pre-designed siRNA Set A
                                            
                                                Med1 Mouse Pre-designed siRNA Set A
                                             
                                    - HY-B0898R
- 
                                        
                                            
                                                | sodium ceftiofur (Standard) | Reference Standards
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        NF-κB
                                                    
                                                        p38 MAPK
                                                    
                                                        TNF Receptor
                                                    
                                                        Interleukin Related | Infection |  
                                                | Ceftiofur sodium (Standard) is the analytical standard of Ceftiofur sodium (HY-B0898). This product is intended for research and analytical applications. Ceftiofur sodium is a cell wall synthesis inhibitor that targets bacterial penicillin-binding proteins (PBPs) and has anti-inflammatory effects in endotoxemia. Ceftiofur sodium exerts bactericidal effects by inhibiting the synthesis of bacterial cell wall peptidoglycan, leading to bacterial cell lysis. Ceftiofur sodium also inhibits the activation of NF-κB and MAPKs, thereby reducing the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6   . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0026R
- 
                                        
                                            
                                                |  | Reference Standards
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        NF-κB
                                                    
                                                        p38 MAPK
                                                    
                                                        TNF Receptor
                                                    
                                                        Interleukin Related | Infection |  
                                                | Ceftiofur hydrochloride (Standard) is the analytical standard of Ceftiofur hydrochloride (HY-B0026). This product is intended for research and analytical applications. Ceftiofur hydrochloride is a cell wall synthesis inhibitor that targets bacterial penicillin-binding proteins (PBPs) and has anti-inflammatory effects in endotoxemia. Ceftiofur hydrochloride exerts bactericidal effects by inhibiting the synthesis of bacterial cell wall peptidoglycan, leading to bacterial cell lysis. Ceftiofur hydrochloride also inhibits the activation of NF-κB and MAPKs, thereby reducing the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6   . |  
 
- 
                                        
                                        
                                              
                                    - HY-N7102R
- 
                                        
                                            
                                                |  | Reference Standards
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        NF-κB
                                                    
                                                        p38 MAPK
                                                    
                                                        TNF Receptor
                                                    
                                                        Interleukin Related | Infection |  
                                                | Ceftiofur (Standard) is the analytical standard of Ceftiofur (HY-N7102). This product is intended for research and analytical applications. Ceftiofur is a cell wall synthesis inhibitor that targets bacterial penicillin-binding proteins (PBPs) and has anti-inflammatory effects in endotoxemia. Ceftiofur exerts bactericidal effects by inhibiting the synthesis of bacterial cell wall peptidoglycan, leading to bacterial cell lysis. Ceftiofur also inhibits the activation of NF-κB and MAPKs, thereby reducing the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6   . |  
 
- 
                                        
                                        
                                              
                                    - HY-B0898S
- 
                                        
                                            
                                                |  | Isotope-Labeled Compounds
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        NF-κB
                                                    
                                                        p38 MAPK
                                                    
                                                        TNF Receptor
                                                    
                                                        Interleukin Related | Infection |  
                                                | Ceftiofur-d3 sodium is deuterium labeled Ceftiofur sodium (HY-B0898). Ceftiofur sodium is a cell wall synthesis inhibitor that targets bacterial penicillin-binding proteins (PBPs) and has anti-inflammatory effects in endotoxemia. Ceftiofur sodium exerts bactericidal effects by inhibiting the synthesis of bacterial cell wall peptidoglycan, leading to bacterial cell lysis. Ceftiofur sodium also inhibits the activation of NF-κB and MAPKs, thereby reducing the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6    . |  
 
- 
                                        
                                        
                                              
                                    - HY-N7101
- 
                                        
                                            
                                                | U-76,252;  CS-807 | Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Penicillin-binding protein (PBP) | Infection |  
                                                | Cefpodoxime Proxetil is an orally active broad spectrum third-generation cephalosporin with potent antibacterial activity against both Gram-positive and Gram-negative bacteria including staphylococci, streptococci, Haemophilus influenzae, Neisseria gonorrhoeae, Escherichia coli, Klebsiella pnuemoniae, Citrobacter spp, and Proteus spp. Cefpodoxime Proxetil binds to penicillin binding proteins (PBPs), which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis. Cefpodoxime Proxetil can be used against skin structure infections, acute otitis media, pharyngitis, tonsillitis, upper respiratory tract infection, urinary tract infections and sexually transmitted diseases     . |  
 
- 
                                        
                                        
                                              
                                    - HY-N6670
- 
                                        
                                            
                                                |  | Antibiotic
                                                    
                                                        Raf
                                                    
                                                        ERK
                                                    
                                                        Ras
                                                    
                                                        MEK
                                                    
                                                        Bacterial | Infection |  
                                                | Cefotetan is a binding agent that targets human Raf1 kinase inhibitor protein (hRKIP). Cefotetan binds to hRKIP, reduces the binding space between hRKIP and Raf1 kinase, relieves hRKIP's inhibition of the Ras/Raf1/MEK/ERK signaling pathway, and enhances ERK phosphorylation. Cefotetan can be used to study diseases associated with dysregulated Ras/Raf1/MEK/ERK signaling pathways. Cefotetan is also a broad-spectrum antibacterial agent that disrupts cell wall synthesis by binding to bacterial penicillin-binding proteins (PBPs). It is used to study bacterial infections such as bone, skin, urinary tract, and lower respiratory tract   . |  
 
- 
                                        
                                        
                                              
                                    - HY-RS10313
- 
                                        
                                            
                                                |  | Small Interfering RNA (siRNA) | Others |  
                                                | PEBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PEBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                 |  
 
- 
                                        
                                            PEBP1 Human Pre-designed siRNA Set A
                                            
                                                PEBP1 Human Pre-designed siRNA Set A
                                             
                                    - HY-N7101R
- 
                                        
                                            
                                                | U-76,252 (Standard); CS-807 (Standard) | Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Penicillin-binding protein (PBP) | Infection |  
                                                | Cefpodoxime Proxetil (Standard) is the analytical standard of Cefpodoxime Proxetil. This product is intended for research and analytical applications. Cefpodoxime Proxetil is an orally active broad spectrum third-generation cephalosporin with potent antibacterial activity against both Gram-positive and Gram-negative bacteria including staphylococci, streptococci, Haemophilus influenzae, Neisseria gonorrhoeae, Escherichia coli, Klebsiella pnuemoniae, Citrobacter spp, and Proteus spp. Cefpodoxime Proxetil binds to penicillin binding proteins (PBPs), which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis. Cefpodoxime Proxetil can be used against skin structure infections, acute otitis media, pharyngitis, tonsillitis, upper respiratory tract infection, urinary tract infections and sexually transmitted diseases     . |  
 
- 
                                        
                                        
                                              
                                    - HY-RS08278
- 
                                        
                                            
                                                |  | Small Interfering RNA (siRNA) | Others |  
                                                | MED1 Human Pre-designed siRNA Set A contains three designed siRNAs for MED1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                 |  
 
- 
                                        
                                            MED1 Human Pre-designed siRNA Set A
                                            
                                                MED1 Human Pre-designed siRNA Set A
                                             
                                    - HY-N7101S
- 
                                        
                                            
                                                | U-76-d7,252-d7;  CS-807-d7 | Isotope-Labeled Compounds
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Penicillin-binding protein (PBP) | Infection |  
                                                | Cefpodoxime proxetil-d7 (U-76-d7,252-d7; CS-807-d7) is the deuterium labeled Cefpodoxime Proxetil (HY-N7101). Cefpodoxime Proxetil is an orally active broad spectrum third-generation cephalosporin with potent antibacterial activity against both Gram-positive and Gram-negative bacteria including staphylococci, streptococci, Haemophilus influenzae, Neisseria gonorrhoeae, Escherichia coli, Klebsiella pnuemoniae, Citrobacter spp, and Proteus spp. Cefpodoxime Proxetil binds to penicillin binding proteins (PBPs), which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis. Cefpodoxime Proxetil can be used against skin structure infections, acute otitis media, pharyngitis, tonsillitis, upper respiratory tract infection, urinary tract infections and sexually transmitted diseases     . |  
 
- 
                                        
                                        
                                              
                                    - HY-RS10933
- 
                                        
                                            
                                                |  | Small Interfering RNA (siRNA) | Others |  
                                                | PPBP Human Pre-designed siRNA Set A contains three designed siRNAs for PPBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                 |  
 
- 
                                        
                                            PPBP Human Pre-designed siRNA Set A
                                            
                                                PPBP Human Pre-designed siRNA Set A
                                             
 
            
            
            
            
            
            
            
            
            
                
                    
                        
                            | Cat. No. | Product Name | Target | Research Area | 
                    
                    
                        
                            
                            - 
                                
                                    - HY-P1116
- 
                                        
                                            
                                                | 
                                                        PBP10
                                                        
                                                            
                                                                
                                                                
                                                                
                                                                    1 Publications Verification | Bacterial | Infection
                                                    
                                                        Inflammation/Immunology |  
                                                | PBP10 is a cell permeable and selective gelsolin-derived peptide inhibitor of formyl peptide receptor 2 (FPR2) over FPR1 . PBP10 is a 10-AA peptide with rhodamine conjugated at its N terminus, exerts bactericidal activity against gram-positive and gram-negative bacteria and limits microbial-induced inflammatory effects . |  
 
 
- 
                                
                                    - HY-P1116A
- 
                                        
                                            
                                                |  | Bacterial | Infection
                                                    
                                                        Inflammation/Immunology |  
                                                | PBP10 is a cell permeable and selective gelsolin-derived peptide inhibitor of formyl peptide receptor 2 (FPR2) over FPR1 . PBP10 is a 10-AA peptide with rhodamine conjugated at its N terminus, exerts bactericidal activity against gram-positive and gram-negative bacteria and limits microbial-induced inflammatory effects . |  
 
 
- 
                                
                                    - HY-P10825
- 
                                        
                                            
                                                |  | DNA/RNA Synthesis | Cancer |  
                                                | p21PBP, a 20 amino-acid peptide, is an inhibitor of DNA replication. p21PBP specifically binds to purified proliferating cell nuclear antigen (PCNA) in tumour cell extracts. p21PBP is promising for research of cancers . |  
 
 
 
            
            
            
            
            
                
                    
                        
                            | Cat. No. | Product Name | Target | Research Area | 
                    
                    
                        
                            
                            - 
                                
                                    - HY-P99537
- 
                                        
                                            
                                                | PBP1510 | Inhibitory Antibodies | Cancer |  
                                                | Ulenistamab (PBP1510) is a first-in-class hunamised IgG1 monoclonal antibody targeting pancreatic adenocarcinoma upregulated factor (PAUF). Ulenistamab can be used for pancreatic cancer (PC) research . |  
 
 
 
            
            
            
                
                    
                        
                            | Cat. No. | Product Name | Category | Target | Chemical Structure | 
                    
                    
                        
                            
                            - 
                                
                                    - HY-D0184R
- 
                                        
                                            
                                                | Deoxycytidine (Standard); Cytosine deoxyriboside (Standard); Deoxyribose cytidine (Standard) | Natural Products
                                                            
                                                            
                                                        
                                                            
                                                            
                                                                Microorganisms
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                            
                                                            
                                                                Endogenous metabolite 
                                                        
                                                     | Reference Standards
                                                    
                                                        Endogenous Metabolite |  
                                                | Cefaclor (monohydrate) (Standard) is the analytical standard of Cefaclor (monohydrate). This product is intended for research and analytical applications. Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections    . |  
 
- 
                                        
                                        
                                              
 
 
            
            
            
                
            
            
            
                
                    
                        
                            | Cat. No. | Product Name | Chemical Structure | 
                    
                    
                        
                            
                            - 
                                
                                    - HY-B0129S
- 
                                        
                                            
                                                |  |  
                                                | Aztreonam-d6 is deuterium labeled Aztreonam. Aztreonam (SQ-26,776) is a synthetic monocyclic beta-lactam antibiotic, which has a very high affinity for penicillin-binding protein 3 (PBP-3). |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-W653936
- 
                                        
                                            
                                                |  |  
                                                | Cephalexin-d5 (hydrate) is deuterium labeled Cephalexin (monohydrate). Cephalexin (Cefalexin) monohydrate is a potent, orally active new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin (Cefalexin) monohydrate has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin (Cefalexin) monohydrate targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin (Cefalexin) monohydrate is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al   . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0198S
- 
                                        
                                            
                                                |  |  
                                                | Cefaclor-d5 is the deuterium labeled Cefaclor. Cefaclor is an effective antibiotic agent, and specifically binds to penicillin-binding protein 3 (PBP 3) . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-W743473
- 
                                        
                                            
                                                |  |  
                                                | Cefetamet-d3 (Ro 15-8074-d3; Deacetoxycefotaxime-d3) is the deuterium labeled Cefetamet (HY-A0111). Cefetamet (Ro 15-8074) is a cephalosporin antibiotic and the active metabolite of Cefetamet pivoxil (HY-B1894A). Cefetamet binds to bacterial penicillin-binding protein (PBP) (IC50 for PBP3 in Escherichia coli W3110 is 2.5 μg/mL). Cefetamet has significant activity against Gram-negative bacteria such as Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria such as Streptococcus. Cefetamet kills and lyses Treponema pallidum. Cefetamet can be used in the research of respiratory tract, urinary tract, ear, nose and throat infections, and syphilis     . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-N7101S1
- 
                                        
                                            
                                                |  |  
                                                | Cefpodoxime Proxetil-d6 (U-76,252-d6) is deuterium labeled Cefpodoxime Proxetil. Cefpodoxime proxetil is an orally administered broad spectrum third-generation cephalosporin. Cefpodoxime proxetil has anti-bacterial activity. Cefpodoxime proxetil binds to penicillin binding proteins (PBPs) which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis  . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-B0898S
- 
                                        
                                            
                                                |  |  
                                                | Ceftiofur-d3 sodium is deuterium labeled Ceftiofur sodium (HY-B0898). Ceftiofur sodium is a cell wall synthesis inhibitor that targets bacterial penicillin-binding proteins (PBPs) and has anti-inflammatory effects in endotoxemia. Ceftiofur sodium exerts bactericidal effects by inhibiting the synthesis of bacterial cell wall peptidoglycan, leading to bacterial cell lysis. Ceftiofur sodium also inhibits the activation of NF-κB and MAPKs, thereby reducing the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6    . |  
 
- 
                                        
                                        
                                              
 
- 
                                
                                    - HY-N7101S
- 
                                        
                                            
                                                |  |  
                                                | Cefpodoxime proxetil-d7 (U-76-d7,252-d7; CS-807-d7) is the deuterium labeled Cefpodoxime Proxetil (HY-N7101). Cefpodoxime Proxetil is an orally active broad spectrum third-generation cephalosporin with potent antibacterial activity against both Gram-positive and Gram-negative bacteria including staphylococci, streptococci, Haemophilus influenzae, Neisseria gonorrhoeae, Escherichia coli, Klebsiella pnuemoniae, Citrobacter spp, and Proteus spp. Cefpodoxime Proxetil binds to penicillin binding proteins (PBPs), which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis. Cefpodoxime Proxetil can be used against skin structure infections, acute otitis media, pharyngitis, tonsillitis, upper respiratory tract infection, urinary tract infections and sexually transmitted diseases     . |  
 
- 
                                        
                                        
                                              
 
 
            
            
            
                
                    
                        
                            | Cat. No. | Compare | Product Name | Application | Reactivity | 
                    
                    
                    
                        
                        
                        
                            
                                Compare Products
                                
                            
                            
                            
                                
                                    
                                        |  | 
                                    
                                        | Products |  | 
                                    
                                        | Cat. No. |  | 
                                    
                                        | Host |  | 
                                    
                                        | Reactivity |  | 
                                    
                                        | Application |  | 
                                    
                                        | Dilution Ratio
 |  | 
                                    
                                        | Molecular Weight |  | 
                                    
                                        | Conjugation |  | 
                                    
                                        | Clonality |  | 
                                    
                                        | Immunogen |  | 
                                    
                                        | Appearance |  | 
                                    
                                        | Isotype |  | 
                                    
                                        | Gene ID |  | 
                                    
                                        | SwissProt ID |  | 
                                    
                                        | Purity |  | 
                                    
                                        | Formulation |  | 
                                    
                                        | Free Sample | Yes
                                            
                                            
                                            No | 
                                    
                                        | Size | 
                                                
                                                
                                                    * This product has been "discontinued".  Optimized version of product available:  | 
                                
                             
                         
                     
                    
                 
            
            
            
                
                
                    
                        
                            
                                | Cat. No. | Product Name |  | Classification | 
                        
                        
                            
                            
                        - 
                            
                                - HY-RS03925
- 
                                    
                                        
                                            |  |  | siRNAs
                                                    
                                                    
                                                
                                                    
                                                    
                                                        Human Pre-designed siRNA Sets |  
                                            | DOCK3 Human Pre-designed siRNA Set A contains three designed siRNAs for DOCK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                
                                                
                                             |  
 
 
- 
                            
                                - HY-RS24550
- 
                                    
                                        
                                            |  |  | siRNAs
                                                    
                                                    
                                                
                                                    
                                                    
                                                        Rat Pre-designed siRNA Sets |  
                                            | Pebp1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Pebp1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                
                                                
                                             |  
 
 
- 
                            
                                - HY-RS00003
- 
                                    
                                        
                                            |  |  | siRNAs
                                                    
                                                    
                                                
                                                    
                                                    
                                                        Human Pre-designed siRNA Sets |  
                                            | PKD1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                
                                                
                                             |  
 
 
- 
                            
                                - HY-RS18075
- 
                                    
                                        
                                            |  |  | siRNAs
                                                    
                                                    
                                                
                                                    
                                                    
                                                        Mouse Pre-designed siRNA Sets |  
                                            | Pebp1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pebp1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                
                                                
                                             |  
 
 
- 
                            
                                - HY-RS18247
- 
                                    
                                        
                                            |  |  | siRNAs
                                                    
                                                    
                                                
                                                    
                                                    
                                                        Mouse Pre-designed siRNA Sets |  
                                            | Med1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Med1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                
                                                
                                             |  
 
 
- 
                            
                                - HY-RS10313
- 
                                    
                                        
                                            |  |  | siRNAs
                                                    
                                                    
                                                
                                                    
                                                    
                                                        Human Pre-designed siRNA Sets |  
                                            | PEBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PEBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                
                                                
                                             |  
 
 
- 
                            
                                - HY-RS08278
- 
                                    
                                        
                                            |  |  | siRNAs
                                                    
                                                    
                                                
                                                    
                                                    
                                                        Human Pre-designed siRNA Sets |  
                                            | MED1 Human Pre-designed siRNA Set A contains three designed siRNAs for MED1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                
                                                
                                             |  
 
 
- 
                            
                                - HY-RS10933
- 
                                    
                                        
                                            |  |  | siRNAs
                                                    
                                                    
                                                
                                                    
                                                    
                                                        Human Pre-designed siRNA Sets |  
                                            | PPBP Human Pre-designed siRNA Set A contains three designed siRNAs for PPBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
                                                
                                                
                                             |  
 
 
 
                
         
        
        
        
        
        
        
            
            Your information is safe with us.  * Required Fields. 
             
        
        
            
            
                
                
                Inquiry Information
                
                    - Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: